1 of 1
Story summary
- 354,957 UK Biobank participants showed coffee consumption linked to lower risks of cirrhosis, liver cancer and liver-related death.
- Compared with non-drinkers, 1–2 cups cut risks by ~20-31%, 3–4 cups by ~35-41%, and five or more cups by ~32-47%.
- Hyunseok Kim, a hepatologist, said MRI and proteomic data boost confidence coffee affects liver biology.
- Dietitian Michelle Routhenstein noted benefits for both decaf and caffeinated coffee suggest polyphenol antioxidants.
